A long-acting flea and tick treatment from Merck Animal Health has earned approval for dogs at least six months old from the Food and Drug Administration (FDA).

The U.S. Food and Drug Administration (FDA) approved Bravecto Quantum, a novel injectable treatment offering dogs up to 12 months of protection against fleas and ticks with a single dose.

FDA approves Bravecto Quantum, the first injectable flea and tick treatment offering dogs up to 12 months of protection.

The FDA has approved a long-acting drug to protect dogs against fleas and ticks. The drug, Bravecto Quantum, is given by injection and must be prescribed by a licensed veterinarian.